{
    "code": "02025706",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025706",
    "time": "2017-05-26 03:48:12",
    "許可證字號": "衛署藥輸字第025706號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/05\/23",
    "發證日期": "101\/05\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202570605",
    "中文品名": "&quot;卡比&quot;葛斯壯靜脈注射液1毫克\/毫升",
    "英文品名": "Granisetron Kabi 1mg\/ml, Concentrate for Solution for Injection\/Infusion",
    "適應症": "預防及治療抗腫瘤化學療法所引起的噁心、嘔吐及治療抗腫瘤放射線療法引起的噁心、嘔吐。預防全身性及半身性抗腫瘤放射線療法引起的噁心、嘔吐。治療手術後引起的噁心、嘔吐。",
    "劑型": "270注射劑",
    "包裝": "1毫升、3毫升玻璃安瓿裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "GRANISETRONHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F360017000  LABESFAL, LABORATORIOS ALMIRO, S.A.",
        "製造廠廠址": "ZONA INDUSTRIAL DO LAGEDO, 3465-157 SANTIAGO DE BESTEIROS, PORTUGAL",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F360020000  FRESENIUS KABI PHARMA PORTUGAL, LDA.",
            "製造廠廠址": "Avenida do Forte, 3 - Edif&#237;cio Suecia III, Piso 2, 2790-073 Carnaxide, Portugal",
            "製造廠公司地址": "",
            "製造廠國別": "PORTUGAL",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5622001410",
            "成分名稱": "GRANISETRON HYDROCHLORIDE",
            "含量描述": "",
            "含量": "1.1200000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "20150611081919930-104-06-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025706&Seq=002&Type=9"
        },
        {
            "title": "全頁相片-104-12-24(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025706&Seq=004&Type=8"
        }
    ]
}